|
|
| CK-0045 / Cytoki Pharma (0 Trials) |
|
| CK-102 / Fortress (0 Trials) |
|
| CK-103 / Fortress, TG Therap (0 Trials) |
|
| CK-136 / Cytokinetics (0 Trials) |
|
| CK-271 / Cytokinetics (0 Trials) |
|
| CK-302 / TG Therap, Fortress (0 Trials) |
|
| CK-303 / Fortress (0 Trials) |
|
| CK-601 / Cytokinetics, Astellas (0 Trials) |
|
| CK0801 / Cellenkos (0 Trials) |
|
| CK0802 / Cellenkos (0 Trials) |
|
| CK0803 / Cellenkos (0 Trials) |
|
| CK0804 / Cellenkos, Incyte (0 Trials) |
|
| CK0805 / Cellenkos (0 Trials) |
|
| CK0807 / Cellenkos (0 Trials) |
|
| CK0808 / Cellenkos (0 Trials) |
|
| CK0809 / Cellenkos (0 Trials) |
|
| CKD-10101 / Chong Kun Dang (0 Trials) |
|
| CKD-12101 (pegfilgrastim biosimilar) / Chong Kun Dang (0 Trials) |
|
| CKD-12201 / Chong Kun Dang (0 Trials) |
|
| CKD-320 / Chong Kun Dang (0 Trials) |
|
| CKD-331 / Chong Kun Dang (0 Trials) |
|
| CKD-333 / Chong Kun Dang (0 Trials) |
|
| CKD-341 / Chong Kun Dang (0 Trials) |
|
| CKD-344 / Chong Kun Dang (0 Trials) |
|
| CKD-349 / Chong Kun Dang (0 Trials) |
|
| CKD-352 / Chong Kun Dang (0 Trials) |
|
| CKD-371 / Chong Kun Dang (0 Trials) |
|
| CKD-375 / Chong Kun Dang (0 Trials) |
|
| CKD-381 / Chong Kun Dang (0 Trials) |
|
| CKD-382 / Chong Kun Dang (0 Trials) |
|
| CKD-385 / Chong Kun Dang (0 Trials) |
|
| CKD-386 / Chong Kun Dang (0 Trials) |
|
| CKD-387 / Chong Kun Dang (0 Trials) |
|
| CKD-388 / Chong Kun Dang (0 Trials) |
|
| CKD-393 / Chong Kun Dang (0 Trials) |
|
| CKD-498 / Chong Kun Dang (0 Trials) |
|
| CKD-504 / Chong Kun Dang (0 Trials) |
|
| CKD-506 / Chong Kun Dang (0 Trials) |
|
| CKD-508 / Chong Kun Dang (0 Trials) |
|
| CKD-510 / Novartis (0 Trials) |
|
| CKD-701 (ranibizumab biosimilar) / Chong Kun Dang (0 Trials) |
|
| CKD-702 / Chong Kun Dang (0 Trials) |
|
| CKD-843 / Chong Kun Dang (0 Trials) |
|
| CKD-902 / Chong Kun Dang (0 Trials) |
|
| CKD-903 / Chong Kun Dang (0 Trials) |
|
| CKD-941 / Chong Kun Dang (0 Trials) |
|
| CKD-942 / Chong Kun Dang (0 Trials) |
|
| CKD-M808 / Chong Kun Dang (0 Trials) |
|
| CL-387785 / Pfizer (0 Trials) |
|
| CL-AT-313 / Charleston Labs (0 Trials) |
|
| CL-AT-413 / Charleston Labs (0 Trials) |
|
| CL-AT-513 / Charleston Labs (0 Trials) |
|
| CL04177 / Cleara Biotech (0 Trials) |
|
| CL04183 / Cleara Biotech (0 Trials) |
|
| CLA-1816 / Claritas Pharma (0 Trials) |
|
| Clade C and Mosaic gp140 HIV bivalent vaccine / J&J (0 Trials) |
|
| cladribine / Generic mfg. (68 Trials) |
|
| cladribine (CRD1) / EMD Serono (0 Trials) |
|
| Clairyg (intravenous normal human immunoglobulin) / LFB SA (2 Trials) |
|
| claramine / Northwestern University (0 Trials) |
|
| clarithromycin / Generic mfg. (143 Trials) |
|
| clarithromycin/clofazimine/rifabutin (RHB-204) / RedHill (0 Trials) |
|
| clazakizumab (CSL300) / CSL Behring (9 Trials) |
|
| CLB-004 / ClostraBio (0 Trials) |
|
| CLB-3000 / ClearB Therap (0 Trials) |
|
| CLBR001/SWI019 / AbbVie (0 Trials) |
|
| CLBS03 / Lisata Therap (0 Trials) |
|
| CLBS119 / Lisata Therap (0 Trials) |
|
| CLBS14 / Lisata Therap (0 Trials) |
|
| CLD-101 / Calidi Biotherap (0 Trials) |
|
| CLD-201 / Calidi Biotherap (0 Trials) |
|
| CLDN 18.2/TGF-β bispecific CAR-T / ImmPACT Bio (0 Trials) |
|
| CLDN18.2 CAR-T cells / Innovative Cellular Therapeutics (0 Trials) |
|
| CLDN18.2 targeted radiopharmaceutical therapeutic / Full-Life Technologies Limited (0 Trials) |
|
| CLDN18.2 UCAR-T / Suzhou Maximum Bio-tech (0 Trials) |
|
| CLDN18.2/CD19 targeted CAR-T / Innovative Cellular Therapeutics (0 Trials) |
|
| CLDN6 CAR-T / CARsgen (0 Trials) |
|
| CLDN6 CAR-T cells / Innovative Cellular Therapeutics (0 Trials) |
|
| CLDN6-CAR-NK cell therapy / Second Affiliated Hospital of Guangzhou Medical University (0 Trials) |
|
| CLDN6/MSLN/GPC3 CART / Innovative Cellular Therapeutics (0 Trials) |
|
| CLE-100 / Clexio Biosci (0 Trials) |
|
| CLE-500 / Clexio Biosci (0 Trials) |
|
| clemizole / Eiger (0 Trials) |
|
| clemizole (EPX-100) / Epygenix Therap (0 Trials) |
|
| clenbuterol (CST-103) / CuraSen Therap (0 Trials) |
|
| Clenil Modulite (beclometasone pressurised metered-dose inhaler) / Chiesi, GSK (0 Trials) |
|
| clenoliximab (IDEC-151) / Biogen (0 Trials) |
|
| clesacostat (PF-05221304) / Pfizer (0 Trials) |
|
| clesrovimab (MK-1654) / Merck (MSD) (0 Trials) |
|
| Clevegen (bexmarilimab) / Faron Pharma (0 Trials) |
|
| CLF065 / Scripps Research Institute, AbbVie (0 Trials) |
|
| CLFB-1134 / Califia Bio (0 Trials) |
|
| CLG561 / Novartis, MorphoSys (0 Trials) |
|
| CLIC-1901 / Ottawa Hospital Research Institute (0 Trials) |
|
| clifutinib (HEC73543) / HEC Pharm (0 Trials) |
|
| Climara (estradiol) / Bausch Health, Bayer (5 Trials) |
|
| clindamycin phosphate / Generic mfg. (95 Trials) |
|
| clindamycin phosphate vaginal gel (DARE-BV1) / Daré Biosci (0 Trials) |
|
| clindamycin/tretinoin / Generic mfg. (4 Trials) |
|
| Clindesse (clindamycin phosphate) / Covis Pharma (0 Trials) |
|
| Clipper (beclometasone) / Chiesi (3 Trials) |
|
| CLL-1, CD33 and/or CD123-specific CAR gene-engineered T cells / SZGIMI (0 Trials) |
|
| CLL1 CAR T / Shanghai Yake Biotech (0 Trials) |
|
| CLL1 CAR-T / Hedy Group, Zhejiang University (0 Trials) |
|
| CLL1 targeting Gamma Delta T cell engager / Shattuck (0 Trials) |
|
| CLL1+CD33 CAR-T / Hedy Group, Zhejiang University (0 Trials) |
|
| CLL1-CD33 cCART cell therapy / iCell Gene Therap (0 Trials) |
|
| CLL1/CD33/CD123 CAR T cells / Hedy Group (0 Trials) |
|
| CLL442 / Novartis (0 Trials) |
|
| CLM-101 / National OncoVenture, CellabMed (0 Trials) |
|
| CLM-103 / CellabMed (0 Trials) |
|
| CLN-049 / Cullinan Oncology (0 Trials) |
|
| CLN-617 / Cullinan Oncology (0 Trials) |
|
| CLN-619 / Cullinan Therap (0 Trials) |
|
| CLN-978 / Cullinan Therap (0 Trials) |
|
| CLN1 gene therapy / Amicus (0 Trials) |
|
| CLN8 gene therapy / Amicus (0 Trials) |
|
| clobazam / Generic mfg. (9 Trials) |
|
| clobazam patch (TAH6601) / Taho Pharma (0 Trials) |
|
| clobetasol nanosuspension (APP13007) / Formosa Labs, AimMax Therap (0 Trials) |
|
| clobetasol propionate ophthalmic nanoemulsion 0.05% (SVT-15473) / Laboratorios SALVAT (0 Trials) |
|
| clobetasol propionate topical / Generic mfg. (12 Trials) |
|
| clocortolone pivalate cream / Generic mfg. (0 Trials) |
|
| Clodivac (diphtheria and tetanus vaccine, adsorbed) / IBSS Biomed (0 Trials) |
|
| clodronate disodium / Generic mfg. (8 Trials) |
|
| clofarabine / Generic mfg. (33 Trials) |
|
| clofazimine inhalational (MNKD-101) / MannKind (0 Trials) |
|
| clomifene citrate / Generic mfg. (30 Trials) |
|
| clomipramine / Generic mfg. (4 Trials) |
|
| clonazepam / Generic mfg. (8 Trials) |
|
| clonazepam intranasal (JZP-8) / Jazz (0 Trials) |
|
| clonidine / Generic mfg. (0 Trials) |
|
| clonidine (ARC 4558) / Collegium Pharma (0 Trials) |
|
| clonidine extended release / Generic mfg. (1 Trials) |
|
| clonidine TDS / Corium, Teva (0 Trials) |
|
| clonidine/oxybutynin (OP-014) / Orient Europharma (0 Trials) |
|
| clopidogrel / Generic mfg. (282 Trials) |
|
| clopidogrel/aspirin / Generic mfg. (2 Trials) |
|
| Clopixol (zuclopenthixol) / Lundbeck (2 Trials) |
|
| clorazepate / Generic mfg. (1 Trials) |
|
| clostridium botulinum neurotoxin serotype A recombinant (IPN59011) / Ipsen (0 Trials) |
|
| Clostridium novyi-NT / BioMed Valley Discoveries (0 Trials) |
|
| clostridium strain (live) / Chain Biotech (0 Trials) |
|
| clotiazepam / Generic mfg. (0 Trials) |
|
| Clotinab (abciximab) / ISU Abxis (4 Trials) |
|
| clotrimazole oral / Generic mfg. (2 Trials) |
|
| clotrimazole topical / Generic mfg. (1 Trials) |
|
| ClowZ Tab (ezetimibe/rosuvastatin) / Daewon Pharma (0 Trials) |
|
| cloxacillin / Generic mfg. (6 Trials) |
|
| ClozaBen (clozapine/sodium benzoate) / SyneuRx (0 Trials) |
|
| clozapine / Generic mfg. (49 Trials) |
|
| clozapine orally disintegrating tablets / Generic mfg. (1 Trials) |
|
| CLP-1001 / Sorbent Therap (0 Trials) |
|
| CLP-1004 / Sorbent Therap (0 Trials) |
|
| CLR 125 / Cellectar (0 Trials) |
|
| CLR 1601-PTX / Cellectar (0 Trials) |
|
| CLR 1602-PTX / Cellectar (0 Trials) |
|
| CLR 1900 Series / Cellectar (0 Trials) |
|
| CLR01 / UCLA (0 Trials) |
|
| CLR1404 / Cellectar (0 Trials) |
|
| CLR325 / Novartis (0 Trials) |
|
| CLR4001 / Clera (0 Trials) |
|
| CLRX-10 / Arrowhead (0 Trials) |
|
| CLS002 / Maruho (0 Trials) |
|
| CLS003 / Maruho (2 Trials) |
|
| CLT-030 / Cellerant Therap (0 Trials) |
|
| clusterin-I peptide (CGEN-25008) / Compugen (0 Trials) |
|
| CLX-090717 / TheracosBio (0 Trials) |
|
| CLX-103 / Cellix Bio (0 Trials) |
|
| CLX-GI-3A5 / Cellix Bio (0 Trials) |
|
| CLX-IFN-59 / Cellix Bio (0 Trials) |
|
| CLX-NEU-61 / Cellix Bio (0 Trials) |
|
| CLX001 / ValiRx (0 Trials) |
|
| CM-10 / Merck (MSD) (0 Trials) |
|
| CM-100 / Life Biosci (0 Trials) |
|
| CM-101 intravenous / ChemomAb (0 Trials) |
|
| CM-101 subcutaneous / ChemomAb (0 Trials) |
|
| CM-182 / Curemark (0 Trials) |
|
| CM-363 / Ceamed (0 Trials) |
|
| CM-4612 / Curemark (0 Trials) |
|
| CM-681 / Ceamed (0 Trials) |
|
| CM-728 / Ceamed (0 Trials) |
|
| CM-AT / Curemark (0 Trials) |
|
| CM-PK / Curemark (0 Trials) |
|
| CM-Yj1 / Pulmatrix, Celdara Medical (0 Trials) |
|
| CM-Yj2 / Celdara Medical (0 Trials) |
|
| CM04S1 / GeoVax (0 Trials) |
|
| CM101 / TumorEnd (0 Trials) |
|
| CM24 / Merck (MSD), Purple Biotech (1 Trials) |
|
| CM2489 / CalciMedica (0 Trials) |
|
| CM3.1-AC100 / Boston Scientific (0 Trials) |
|
| CM313 / Keymed Biosciences (0 Trials) |
|
| CM326 / Keymed Biosciences (0 Trials) |
|
| CM336 / Keymed Biosciences (0 Trials) |
|
| CM338 / Keymed Biosciences (0 Trials) |
|
| CM3457 / CalciMedica (0 Trials) |
|
| CM350 / Keymed Biosciences (0 Trials) |
|
| CM355 / Keymed Biosciences, InnoCare (0 Trials) |
|
| CM93 / Crimson Biopharm (0 Trials) |
|
| CMAB 819 (nivolumab biosimilar) / Mabpharm Limited (0 Trials) |
|
|